Overdoses and deaths related to the use of ketamine and its analogues: a systematic review

References

• Carlini C, Andreoni S, Martins SS, Benjamin M, Sanudo A, Sanchez ZM. Environmental characteristics associated with alcohol intoxication among patrons in Brazilian nightclubs. Drug Alcohol Rev. 2014;33:358–66.
   PubMed Web of Science ®Google Scholar
• Hillemacher T, Bleich S, Demling J, Kornhuber J. Ketamine for the treatment of depression: what about the addictive potential? Aust NZ J Psychiatry. 2007 09;41:772–73.
   PubMed Web of Science ®Google Scholar
• Kolar D. Addictive potential of novel treatments for refractory depression and anxiety. Neuropsychiatr Dis Treat. 2018;14:1513–19.
   PubMed Web of Science ®Google Scholar
• Lankenau SE, Sanders B, Bloom JJ, Hathazi D, Alarcon E, Tortu S, Clatts MC. First injection of ketamine among young injection drug users (IDUs) in three U.S. cities. Drug Alcohol Depend. 2007 Mar 16;87:183–93. doi:10.1016/j.drugalcdep.2006.08.015.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lin D, Wu B, Zhou W. Ketamine abuse potential and use disorder. Brain Res Bull. 2016;126:68–73.
   PubMed Web of Science ®Google Scholar
• World Health Organization Expert Committee on Drug Dependence. Ketamine: expert peer review on critical review report (2). Hammamet (Tunisia); 2012.
   Google Scholar
• Yang CC, Lu YL, Wu ML, Lin CC. Ketamine abuse related illnesses: a rapidly emerging problem in Taiwan. Clin Toxicol. 2010;48:305.
   Web of Science ®Google Scholar
• Yiu-Cheung C. Acute and chronic toxicity pattern in ketamine abusers in Hong Kong. J Med Toxicol. 2012;8:267–70.
   PubMedGoogle Scholar
• European Monitoring Centre for Drugs and Drug Addiction. Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities; 2002.
   Google Scholar
• Domino EF, Chodoff P, Corssen G. Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clin Pharmacol Ther. 1965;6:279–91.
   PubMed Web of Science ®Google Scholar
• Domino EF. Taming the ketamine tiger. 1965. Anesthesiology. 2010 Sep;113:678–84.
   PubMed Web of Science ®Google Scholar
• Jansen KLR, Darracot-Cankovic R. The nonmedical use of ketamine, part two: a review of problem use and dependence. J Psychoact Drugs. 2001;33:151–58.
   PubMed Web of Science ®Google Scholar
• Moore NN, Bostwick JM. Ketamine dependence in anesthesia providers. Psychosomatics. 1999;40:356–59. doi:10.1016/S0033-3182(99)71231-4.
   PubMed Web of Science ®Google Scholar
• Sidoff ML. Phencyclidine: syndromes of abuse and modes of treatment. Top Emerg Med. 1979;1:111–19.
   Google Scholar
• Bertron JL, Seto M, Lindsley CW. DARK classics in chemical neuroscience: phencyclidine (PCP). ACS Chem Neurosci. 2018;9:2459–74. doi:10.1021/acschemneuro.8b00266.
   PubMed Web of Science ®Google Scholar
• Jansen KLR, Theron L. Ketamine: further observations on use, users and consequences. Adicciones; Ketamina: Nuevas observaciones sobre su consumo, consumidores y efectos. 2003;15:135–66.
   Google Scholar
• Bäckberg M, Beck O, Helander A. Phencyclidine analog use in Sweden - intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project. Clin Toxicol (Phila). 2015 Nov;53:856–64.
   PubMed Web of Science ®Google Scholar
• Kalsi SS, Wood DM, Dargan PI. The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threat J. 2011;4:7107. doi:10.3402/ehtj.v4i0.7107.
   PubMedGoogle Scholar
• Hong Kong: Narcotics Division, Security Bureau. Central registry of drug abuse: selected drug abuse statistics; 2010.
   Google Scholar
• Chong YK, Tang MH, Chan CL, Li YK, Ching CK, Mak TW. 2-oxo-PCE: ketamine analogue on the streets. Hong Kong Med J. 2017 Dec;23:665–66.
   PubMed Web of Science ®Google Scholar
• da Silva FCC, Dantas RT, Citó MCO, Silva MIG, de Vasconcelos SMM, Fonteles MMF, Viana GSB, de Sousa FCF. Ketamine, from anesthesia to abusive use: review article. Rev Neurocienc. 2010;18:227–37.
   Google Scholar
• Critchlow DG. A case of ketamine dependence with discontinuation symptoms. Addiction. 2006;101:1212–13. doi:10.1111/j.1360-0443.2006.01494.x.
   PubMed Web of Science ®Google Scholar
• Dalgarno PJ, Shewan D. Illicit use of ketamine in Scotland. J Psychoact Drugs. 1996;28:191–99.
   PubMed Web of Science ®Google Scholar
• Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994 Mar;51:199–214.
   PubMed Web of Science ®Google Scholar
• Muetzelfeldt L, Kamboj SK, Rees H, Taylor J, Morgan CJ, Curran HV. Journey through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend. 2008 Jun 1;95:219–29.
   PubMed Web of Science ®Google Scholar
• Orhurhu VJ, Vashisht R, Claus LE, Cohen SP. Ketamine toxicity. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
   Google Scholar
• Sarton E, Teppema LJ, Olievier C, Nieuwenhuijs D, Matthes HWD, Kieffer BL, Dahan A. The Involvement of the μ-opioid receptor in ketamine-induced respiratory depression and antinociception. Anesthesia Analgesia. 2001;93:1495–500. doi:10.1097/00000539-200112000-00031.
   PubMed Web of Science ®Google Scholar
• Ng SH, Tse ML, Ng HW, Lau FL. Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. Hong Kong Med J. 2010;16:6–11.
   PubMedGoogle Scholar
• Narendran R, Gordon FW, Keefe R, Gil R, Martinez D, Slifstein M, Kegeles LS, Talbot PS, Huang Y, Hwang D-R, et al. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry. 2005;162:2352–59. doi:10.1176/appi.ajp.162.12.2352.
   PubMed Web of Science ®Google Scholar
• Bokor G, Anderson PD. Ketamine: an update on its abuse. J Pharm Pract. 2014 Dec;27:582–86.
   PubMedGoogle Scholar
• Vroegop MP, van Dongen RT, Vantroyen B, Kramers C. Ketamine as a party drug. Ned Tijdschr Geneeskd. 2007 Sep 15;151:2039–42.
   PubMedGoogle Scholar
• Lankenau SE, Clatts MC. Patterns of polydrug use among ketamine injectors in New York City. Subst Use Misuse. 2005;40:1381–97+1583.
   PubMed Web of Science ®Google Scholar
• Dillon P, Copeland J, Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend. 2003 Jan 24;69:23–28.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma GroupMoher D, Liberati A, Tetzlaff J, Altman DG, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. doi:10.1371/journal.pmed.1000097.
   PubMed Web of Science ®Google Scholar
• Mozayani A, Schrode P, Carter J, Danielson TJ. A multiple drug fatality involving MK-801 (dizocilpine), a mimic of phencyclidine. Forensic Sci Int. 2003;133:113–17.
   PubMed Web of Science ®Google Scholar
• Adamowicz P, Zuba D. Fatal intoxication with methoxetamine. J Forensic Sci. 2015;60:S264–68.
   PubMed Web of Science ®Google Scholar
• Breitmeier D, Passie T, Mansouri F, Albrecht K, Kleemann WJ. Autoerotic accident associated with self-applied ketamine. Int J Leg Med. 2002;116:113–16.
   PubMed Web of Science ®Google Scholar
• Chiappini S, Claridge H, Corkery JM, Goodair C, Loi B, Schifano F. Methoxetamine-related deaths in the UK: an overview. Hum Psychopharmacol. 2015;30:244–48.
   PubMed Web of Science ®Google Scholar
• Dinis-Oliveira RJ, Carvalho F, Duarte JA, Dias R, Magalhães T, Santos A. Suicide by hanging under the influence of ketamine and ethanol. Forensic Sci Int. 2010;202:e23–27.
   PubMed Web of Science ®Google Scholar
• Lalonde BR, Wallage HR. Postmortem blood ketamine distribution in two fatalities. J Anal Toxicol. 2004;28:71–74.
   PubMed Web of Science ®Google Scholar
• Mitchell-Mata C, Thomas B, Peterson B, Couper F. Two fatal intoxications involving 3-methoxyphencyclidine. J Anal Toxicol. 2017;41:503–07.
   PubMed Web of Science ®Google Scholar
• Wiergowski M, Anand JS, Krzyzanowski M, Jankowski Z. Acute methoxetamine and amphetamine poisoning with fatal outcome: a case report. Int J Occup Med Environ Health. 2014 Aug;27:683–90.
   PubMed Web of Science ®Google Scholar
• Theofel N, Moller P, Vejmelka E, Kastner K, Roscher S, Scholtis S, Tsokos M. A fatal case involving N-Ethyldeschloroketamine (2-Oxo-PCE) and Venlafaxine. J Anal Toxicol. 2019 Mar 1;43:e2–6. doi:10.1093/jat/bky063.
   PubMed Web of Science ®Google Scholar
• Wikström M, Thelander G, Dahlgren M, Kronstrand R. An accidental fatal intoxication with methoxetamine. J Anal Toxicol. 2013 Jan–Feb;37:43–46.
   PubMed Web of Science ®Google Scholar
• Tao LY, Chen XP, Qin ZH. A fatal chronic ketamine poisoning. J Forensic Sci. 2005;50:173–76.
   PubMed Web of Science ®Google Scholar
• Licata M, Pierini G, Popoli G. A fatal ketamine poisoning. J Forensic Sci. 1994;39:1314–20.
   PubMed Web of Science ®Google Scholar
• Gill JR, Stajíc M. Ketamine in non-hospital and hospital deaths in New York City. J Forensic Sci. 2000 May;45:655–58.
   PubMed Web of Science ®Google Scholar
• Gaillard Y, Pépin G. Evidence of polydrug use using hair analysis: a fatal case involving heroin, cocaine, cannabis, chloroform, thiopental and ketamine. J Forensic Sci. 1998 Mar;43:435–38.
   PubMed Web of Science ®Google Scholar
• Moore KA, Kilbane EM, Jones R, Kunsman GW, Levine B, Smith M. Tissue distribution of Ketamine in a mixed drug fatality. J Forensic Sci. 1997;42:1183–85.
   PubMed Web of Science ®Google Scholar
• Peyton SH, Couch AT, Bost RO. Tissue distribution of ketamine: two case reports. J Anal Toxicol. 1988;12:268–69.
   PubMed Web of Science ®Google Scholar
• Schifano F, Corkery J, Oyefeso A, Tonia T, Ghodse AH. Trapped in the “K-hole”: overview of deaths associated with ketamine misuse in the UK (1993-2006). J Clin Psychopharmacol. 2008 Feb;28:114–16.
   PubMed Web of Science ®Google Scholar
• Bonnet U. LoNg-term ketamine self-injections in major depressive disorder: focus on tolerance in ketamine’s antidepressant response and the development of ketamine addiction. J Psychoactive Drugs. 2015 Sep–Oct;47:276–85.
   PubMed Web of Science ®Google Scholar
• Bowman CF, Pruitt B, Marx J, Thornton SL. Massive iatrogenic pediatric ketamine overdose with serial levels and minimal morbidity. Pediatr Emerg Care. 2019;37:e1711–e1713.
   Web of Science ®Google Scholar
• Capapé S, Mora E, Mintegui S, Garcia S, Santiago M, Benito J. Prolonged sedation and airway complications after administration of an inadvertent ketamine overdose in emergency department. Eur J Emerg Med. 2008 Apr;15:92–94.
   PubMed Web of Science ®Google Scholar
• Coger K, Donnelly M. Over-sedation with ketamine. Reg Anesth Pain Med. 2016;41.
   Google Scholar
• Green SM, Clark R, Hostetler MA, Cohen M, Carlson D, Rothrock SG. Inadvertent ketamine overdose in children: clinical manifestations and outcome. Ann Emerg Med. 1999;34:492–97.
   PubMed Web of Science ®Google Scholar
• Tang MHY, Chong YK, Chan CY, Ching CK, Lai CK, Li YK, Mak TWL. Cluster of acute poisonings associated with an emerging ketamine analogue, 2-oxo-PCE. Forensic Sci Int. 2018 Sep;290:238–43. doi:10.1016/j.forsciint.2018.07.014.
   PubMed Web of Science ®Google Scholar
• Warner LL, Smischney N. Special K with no license to kill: accidental ketamine overdose on induction of general anesthesia. Am J Case Rep. 2018;19:10–12.
   PubMed Web of Science ®Google Scholar
• Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Pharmacol. 2012 May;68:853–56.
   PubMed Web of Science ®Google Scholar
• Chaves TV, Wilffert B, Sanchez ZM. The use of ketamine to cope with depression and post-traumatic stress disorder: a qualitative analysis of the discourses posted on a popular online forum. Am J Drug Alcohol Abuse. 2020 Sep 02;46:613–24.
   PubMed Web of Science ®Google Scholar
• Skinner HA. The drug abuse screening test. Addict Behav. 1982;7:363–71.
   PubMed Web of Science ®Google Scholar
• Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull. 1986;22:343–81.
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction, Europol. EU drug markets report; 2013.
   Google Scholar
• Luethi D, Liechti ME. Designer drugs: mechanism of action and adverse effects. Arch Toxicol. 2020 Apr;94:1085–133.
   PubMed Web of Science ®Google Scholar
• Hong YL, Yee CH, Tam YH, Wong JH, Lai PT, Ng CF. Management of complications of ketamine abuse: 10 years’ experience in Hong Kong. Hong Kong Med J. 2018 Apr;24:175–81.
   PubMed Web of Science ®Google Scholar
• Joe-Laidler K, Hunt G. Sit down to float: the cultural meaning of ketamine use in Hong Kong. Addict Res Theory. 2008 06;16:259–71.
   PubMed Web of Science ®Google Scholar
• Lee HKH, Ng HW, Tse ML, Lau FL. A retrospective survey on the clinical presentation of ketamine abusers in a hong kong emergency department. Hong Kong J Emerg Med. 2011;18:210–16.
   Web of Science ®Google Scholar
• Hsu LY. Ketamine use in Taiwan: moral panic, civilizing processes, and democratization. Int J Drug Policy. 2014 Jul;25:819–22.
   PubMed Web of Science ®Google Scholar
• Jau P-Y, Chang S-C, Wei H-T, Hsu C-H. The assessment of traditional Chinese medicine constitutions accompanied by psychological conditions of adult males with ketamine abuse in Taiwan. Alcohol Clin Exp Res. 2018;42:49A.
   Web of Science ®Google Scholar
• Lee KH, Yeh YC, Yang PC, Lin HC, Wang PW, Liu TL, Yen C-F. Individual and peer factors associated with ketamine use among adolescents in Taiwan. Eur Child Adolesc Psychiatry. 2012 Oct;21:553–58. doi:10.1007/s00787-012-0292-7.
   PubMed Web of Science ®Google Scholar
• Wang S-C, Zhao Y, Huang C, Tsou H. Community ketamine users in Taiwan: a social network approach. J Neuroimmune Pharmacol. 2017;12:S112.
   Google Scholar
• Fan N, Xu K, Ning Y, Wang D, Ke X, Ding Y, Sun B, Zhou C, Deng X, Rosenheck R, et al. Development of a checklist of short-term and long-term psychological symptoms associated with ketamine use. Shanghai Arch Psychiatry. 2015 Jun 25;27:186–94. doi:10.11919/j.issn.1002-0829.214158.
   PubMedGoogle Scholar
• Fernández-Calderón F, Vidal-Giné C, López-Guerrero J, Lozano-Rojas OM. Reliability, convergent and structural validity and cut-off score of the severity of dependence scale for recreational ketamine users. Addict Behav. 2016 Sep;60:1–7.
   PubMed Web of Science ®Google Scholar